Whats happening at Entrada Therapeutics Entrada is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. Through proprietary and versatile approaches Entrada is advancing a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases among others. Our lead oligonucleotide programs are in development for the potential treatment of people living with Duchenne muscular dystrophy (DMD) who are exon 44 45 50 and 51 skipping amenable. Entrada has partnered with Vertex Pharmaceuticals to develop a clinical-stage program VX-670 for myotonic dystrophy type 1 (DM1).
2026 represents a catalyst-rich period for Entrada. We expect multiple clinical data readouts as we advance several DMD programs across the U.K. EU and U.S. By year-end 2026 we anticipate four clinical-stage programs in our DMD franchise (ENTRENTRENTRand ENTR-601-51). These programs are complemented by the ongoing clinical progress of our DM1 collaboration with Vertex (VX-670).
We are a tight-knit team of experts and leaders in both therapeutic development and rare diseases and are excited to grow and attract colleagues who are ready to join a high-energy dedicated team that likes to get things done and dramatically improve the lives of patients and their families.
You are excited about the opportunity to lead clinical biomarker development and strategy at Entrada. You enjoy a fast-paced environment and juggling competing priorities. You bring an in-depth knowledge of biomarker development and strategy as well as a broad understanding of regulatory expectations supporting assay performance across various stages of clinical development. You follow up and follow through efficiently connecting problems with solutions. You work successfully in a team environment with strong people skills to effectively build working relationships inside and outside of the company.
The Associate Director Clinical Biomarkers will lead scientific efforts in developing and executing biomarker activities to support on-going and new clinical trials. This position will lead both at external CROs and specialty labs and perform technical and strategic assessments of new and innovative biomarker platforms to support Entradas drug development pipeline. Additionally this role will support and lead the internal biomarker team to provide mentorship and training to team members of various levels of skill and competencies. The candidate must possess effective project management skills and communicate progress and risks toward the timely delivery of biomarker assays to support clinical programs.
At Entrada our passion for science our devotion to patients and our values drives ourbehavior:
To thrive on our team you will need to come with:
At Entrada Therapeutics we understand that compensation and total rewards are a major consideration when exploring a new opportunity. We believe in transparency and equity and are committed to sharing salary ranges for every position along with insight into our compensation philosophy in accordance with certain state requirements in the United States and fostering a fair and open environment at the onset.
But we also know it is more than just pay. When you join Entrada youll be part of a mission-driven team with access to comprehensive health dental and vision coverage; life and disability insurance; with a 401(k) match. We pride ourselves on offering competitive benefits that empower our employees and reflect the value of their contributions offering paid gender-inclusive parental leave holistic support for your health and well-being education reimbursement discretionary time off and commuting benefits aligned to your working model. If you find yourself working from our office in Bostons Seaport District this puts you steps away from some of the best the city has to offer.
Our approach to compensation is grounded in transparency equity and performance for the unique contributions each person brings. At Entrada we know that meaningful work deserves meaningful reward and we view compensation as one way we show appreciation for the collaboration curiosity and commitment that drive our mission forward.
Kerry Robert SVP of People
The salary for this opportunity ranges from $173000 - $206000. The final base compensation offered will depend on several considerations which include but may not be limited to a candidates skills competencies experience and other job-related factors permitted by law. The final salary offered may fall outside of this range. #LI-JF1 #LI-Hybrid
Entrada Therapeutics is an equal opportunity employer. Qualified candidates will receive consideration for employment without regard to race color religion national origin gender sexual orientation gender identity or expression age mental or physical disability and genetic information marital status citizenship status military status protected veteran status or any other category protected by law.
Entrada does not accept unsolicited resumes from any source other than directly from candidates. For the protection of all parties involved in the recruiting process resumes will only be accepted from recruiters/agencies if a signed agreement is in place at the inception of the recruiting effort and authorized for a specified position. Unsolicited resumes sent to Entrada from recruiters/agencies do not constitute any type of relationship between the recruiter/agency and Entrada and do not obligate Entrada to pay fees if we hire from those resumes.
Entrada Therapeutics Inc. (the Entrada we us or our) respects your privacy and we want you to be familiar with how we collect use share or otherwise process your Personal Information. Please reference our privacy statement here to understand how and when your data is being used.
Required Experience:
Director
Overcoming the challenge of intracellular target access to transform the treatment of devastating diseases.